Drug maker to pay Utah for $8.5M to settle case

SALT LAKE CITY (AP) — Utah will receive $8.5 million from a drug maker accused of making misleading claims about a new drug for diabetes.

GlaxoSmithKline admitted no wrongdoing in agreeing to settle a lawsuit filed by the Utah Attorney General’s Office.

The Utah Attorney General’s Office alleged GlaxoSmithKline marketed Avandia nationwide as a “wonder drug” offering a “significant advance” in diabetes treatment, despite evidence it increases the risk of heart attacks for certain users.

Assistant Attorney General Robert Morton represented the state in the negotiations with help from private law firms.

KSN.com provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language, racial slurs or consistent name calling will be banned. Please be respectful of the opinions of others. If you see an inappropriate comment, please flag it for our moderators to review.

blog comments powered by Disqus